Healthcare & Life Sciences

As the cosmetic dentistry market booms, practitioners face a new challenge: untangling AI-generated health myths and fixing the hidden costs of at-home bleaching.

Facing a massive 2027 debt wall, EyeCare Partners is selling its optometry arm. The move signals the collapse of the unified eye care consolidation model.

MyEyeDr.'s acquisition of 300 optometry clinics from EyeCare Partners reveals the quiet, debt-driven unraveling of private equity's vision care mega-platforms.

By adding a sitting MedPAC commissioner and a former U.S. Senator to its board, Clover Health signals a strategic shift toward regulatory mastery.

Apex Dental Partners just marked its eighth year on the Inc. 5000. The secret? A decentralized model that hides corporate machinery behind local shingles.

Discover how Dr. Jonathan Piccini is transforming atrial fibrillation treatment by bridging academic electrophysiology with real-world patient advocacy.

As U.S. fertility clinics launch aggressive roadshows across Greater China, we examine the strategic use of regulatory arbitrage and influencer marketing.

Energy magnate Harold Hamm's record $150 million gift to the University of Oklahoma isn't just philanthropy—it's a calculated strike at systemic vulnerability.

As Camp Boggy Creek marks 30 years, we analyze the clinical engineering and philanthropic strategy behind Florida's premier zero-cost pediatric medical retreat.

As regulatory headwinds clear and a new CEO takes the helm, Omega Healthcare Investors is shifting from passive landlord to active global operator.

The American Association of Endodontists swept the PRSA Skyline Awards by treating viral TikTok misinformation as a critical market threat.

The Cigna Group’s latest research proves that paid volunteer time isn’t just a PR stunt—it’s a vital tool for health, retention, and AI-era skill building.

With 1.5 billion people affected by Neglected Tropical Diseases, the GHIT Fund's new digital encyclopedia aims to translate public awareness into R&D capital.

Pinnaql names Allison Kerska CEO in a textbook private equity move, shifting from an acquisition-led build-out to a new phase of operational scaling.

Rome rolls out the red carpet for Chinese investors at CIFIT, targeting high-tech sectors. But can it balance economic ambition with geopolitical de-risking?

VensureHR’s new Direct Care offering isn't just another benefit. It’s a systemic shift, pushing a disruptive healthcare model into the corporate mainstream.

During Sickle Cell Awareness Month, a powerful women's group is showing how local action can address a national health equity issue, one donor at a time.

With new board members from Pfizer and Grifols, the DARPA-inspired health nonprofit signals its intent to bridge the gap from lab research to real-world impact.

As Chemed preps its investor pitch, its hospice arm soars while its plumbing giant faces a digital reckoning. Will a potential divestiture be the answer?

IVI RMA's acquisition of Illume Fertility isn't just a business deal. It's a sign of industry-wide consolidation reshaping patient access and innovation.